SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009181
Filing Date
2018-11-09
Accepted
2018-11-09 16:32:36
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20180930x10q.htm 10-Q 1592017
2 EX-31.1 axsm-20180930ex311e619cc.htm EX-31.1 12064
3 EX-31.2 axsm-20180930ex312b690a0.htm EX-31.2 11288
4 EX-32.1 axsm-20180930ex3211a9f60.htm EX-32.1 5903
5 EX-32.2 axsm-20180930ex3221e1557.htm EX-32.2 5876
  Complete submission text file 0001558370-18-009181.txt   4631410

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20180930.xml EX-101.INS 834862
7 EX-101.SCH axsm-20180930.xsd EX-101.SCH 31198
8 EX-101.CAL axsm-20180930_cal.xml EX-101.CAL 30237
9 EX-101.DEF axsm-20180930_def.xml EX-101.DEF 74747
10 EX-101.LAB axsm-20180930_lab.xml EX-101.LAB 290494
11 EX-101.PRE axsm-20180930_pre.xml EX-101.PRE 206949
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 181173529
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1